Legal controls on cannabimimetics: an international dilemma? (Q44229442)

1 December 2017

Legal controls on cannabimimetics: an international dilemma? (English)

1 reference

1 December 2017

L A King

1

1 reference

1 December 2017

23 July 2013

1 reference

Drug Testing and Analysis

1 December 2017

1 reference

1 December 2017

6

1 reference

1 December 2017

1-2

1 reference

1 December 2017

80-87

1 reference

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

1 December 2017

1 reference

Medical use of cannabis. Cannabidiol: a new light for schizophrenia?

21 January 2018

1 reference

Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment

21 January 2018

1 reference

Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis

21 January 2018

1 reference

The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo

21 January 2018

1 reference

'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?

21 January 2018

1 reference

Reference materials for new psychoactive substances

21 January 2018

1 reference

In vitro approaches to studying the metabolism of new psychoactive compounds

21 January 2018

1 reference

The emergence and analysis of synthetic cannabinoids

21 January 2018

1 reference

Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol

21 January 2018

1 reference

A brief history of 'new psychoactive substances'.

21 January 2018

1 reference

Allosteric modulation of the cannabinoid CB1 receptor

21 January 2018

1 reference

URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products

21 January 2018

1 reference

Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist

21 January 2018

1 reference

Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models

21 January 2018

1 reference

Using dopamine research to generate rational cannabinoid drug policy

21 January 2018

1 reference

Effects of Schedule I drug laws on neuroscience research and treatment innovation.

21 January 2018

1 reference

Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

The new psychoactive substances regime in New Zealand: a different approach to regulation

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/DTA.1510

1 reference

1 December 2017

1 reference

PubMed ID

23881527